Researchers at NYU Abu Dhabi, in partnership with the Cleveland Clinic, have developed a groundbreaking, seed-sized implant that could change how we treat nerve-related conditions. Unlike traditional neuromodulation devices, which require invasive surgery to position wires and a separate incision to house a battery pack, this new implant is injected via a standard needle. It operates without a battery, receiving power wirelessly from an external source, which allows doctors to monitor and adjust nerve stimulation in real time. Because it eliminates the need for surgical leads and battery replacements, this technology promises a safer, less disruptive alternative for patients suffering from chronic pain and movement disorders.

Currently in the preclinical research stage, the device has already shown impressive accuracy in stimulating nerves within living tissue. Its design offers the added benefit of being trackable through standard imaging like ultrasound and CT scans, a significant improvement over existing implants. While the technology has not yet been tested in humans, it represents a major step toward making therapies more accessible and less intimidating. By bridging the gap between non-invasive treatments and complex surgical implants, this innovation could eventually transform the standard of care for the millions of people worldwide who struggle with chronic pain.